Afferent Pharmaceuticals (Series C)

Funding Details
Awarder
Inbox
Date Award
July 09, 2015
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$55,000,000

Company Info
Company Description
Afferent Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines to treat chronic pain.
Market
Neurogenic disorders
Location
San Mateo, California, USA
Coinvestors
Fidelity Management & Research Company, Jennison Associates, New Leaf Venture Partners, Partner Fund Management, Redmile Group, Tekla Healthcare Investors, Tekla Life Science Investors

Links